J 2014

Autoimmune pancreatitis

DITE, Petr; Hana NECHUTOVÁ; Magdalena UVIROVÁ; Jana DVORACKOVA; Bohuslav KIANIČKA et al.

Základní údaje

Originální název

Autoimmune pancreatitis

Autoři

DITE, Petr; Hana NECHUTOVÁ; Magdalena UVIROVÁ; Jana DVORACKOVA; Bohuslav KIANIČKA a Arnost MARTINEK

Vydání

Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc, Czech Republic, Olomouc, Palacky University, 2014, 1213-8118

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 1.200

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/14:00076556

Organizační jednotka

Lékařská fakulta

EID Scopus

Klíčová slova anglicky

chronic pancreatitis; autoimmune pancreatitis; immunoglobulines; IgG4; steroids; extrapancreatic lesions; pancreatic biopsy

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 23. 9. 2014 13:55, Soňa Böhmová

Anotace

V originále

Introduction. Autoimmune pancreatitis (AIP) is the specific type of chronic pancreatitis due to autoimmune background and mechanism. Characteristics. The main clinical symptoms of AIP are obstructive jaundice and abdominal discomfort. The typical histological findings are lymphocytes and IgG4 plasma cells infiltration, fibrosis and venulitis within pancreatic gland. Plasma level of IgG4 is usually extremely high. Objectives. Diagnosis: High level IgG4 positive plasma cells in serum, lymphoplasmatic infiltration found on histological staining of pancreatic tissue, "sausage-like" pancreas in ultrasound and CT scans, and response to steroid therapy are crucial for making of diagnosis. Classification of AIP: AIP can be classified into two subtypes. Type 1 was recognized as the pancreatic manifestation of multiorgan disorder, called IgG4 related disease. Type 2 is a pancreas-specific disorder not associated with IgG4, with similar histological signs as type 1, but also with the positivity of GEL (granulocythic epithelial lesion). Results. Therapy: Due to its high effectivity in AIP treatment, steroid therapy is the first-line option. The alternative therapy is using immunosuppressants (azathioprine). Recently, there are also first experience in biological therapy already published. Conslusion. Before the start of AIP therapy - the differential diagnosis between pancreatic cancer and AIP is essential.